Allali-Hassani, Abdellah
Szewczyk, Magdalena M.
Ivanochko, Danton
Organ, Shawna L.
Bok, Jabez
Ho, Jessica Sook Yuin http://orcid.org/0000-0003-2234-2602
Gay, Florence P. H.
Li, Fengling
Blazer, Levi
Eram, Mohammad S.
Halabelian, Levon http://orcid.org/0000-0003-4361-3619
Dilworth, David http://orcid.org/0000-0001-5557-9476
Luciani, Genna M. http://orcid.org/0000-0001-8107-2708
Lima-Fernandes, Evelyne http://orcid.org/0000-0002-3628-9745
Wu, Qin
Loppnau, Peter
Palmer, Nathan
Talib, S. Zakiah A. http://orcid.org/0000-0002-6063-254X
Brown, Peter J. http://orcid.org/0000-0002-8454-0367
Schapira, Matthieu http://orcid.org/0000-0002-1047-3309
Kaldis, Philipp http://orcid.org/0000-0002-7247-7591
O’Hagan, Ronan C.
Guccione, Ernesto
Barsyte-Lovejoy, Dalia http://orcid.org/0000-0002-6560-9621
Arrowsmith, Cheryl H. http://orcid.org/0000-0002-4971-3250
Sanders, John M. http://orcid.org/0000-0002-3788-4220
Kattar, Solomon D.
Bennett, D. Jonathan http://orcid.org/0000-0003-0163-7479
Nicholson, Benjamin
Vedadi, Masoud http://orcid.org/0000-0002-0574-0169
Article History
Received: 22 April 2019
Accepted: 15 November 2019
First Online: 17 December 2019
Competing interests
: R. O’Hagan, J. M. Sanders, S. D. Kattar, D. J. Bennett and B. Nicholson are current or former employees of Merck Sharp & Dohme Corp., a subsidiary of Merck & Co., Inc., Kenilworth, New Jersey, USA and may own stock or stock options in Merck & Co., Kenilworth, NJ, USA. E.G. has received research funding from Eli-Lilly and Prelude Therapeutics, has served as a consultant for Prelude Therapeutics, SK Biopharmaceuticals Korea and has served on advisory board for LION TCR and Janssen, he is a co-founder of ImmuNOA Pte. Ltd. All other authors declare no competing interests.